Hypertension is a common noncommunicable disease (NCD) and a silent threat to the overall health of an individual. The disease accounts for approximately 45% of deaths due to heart disease, and 51% of deaths due to stroke, globally, and exerts a substantial burden on healthcare systems worldwide, as well as in emerging economies such as India.  National surveys, meta-analyses, and several studies have highlighted the increasing prevalence and burden of hypertension in India, in both urban and rural settings. This coupled with the lack of disease awareness among the general population further complicates the management of hypertension in India. Advancing age, alcohol and tobacco intake, smoking, obesity, high consumption of dietary fat and salt, and sedentary lifestyle are significant risk factors for hypertension in India. 

Ironically, despite the availability of various tools to diagnose and treat hypertension, a substantial proportion of patients exhibit uncontrolled hypertension in India. The inefficient management of the disease, thus, makes patients prone to a range of serious complications, such as coronary artery disease, myocardial infarction, cardiac failure, renal insufficiency, and eventually death. One of the key factors contributing to uncontrolled hypertension in India is the lack of adherence to the prescribed treatment agent and regimen. Poor adherence to treatment not only has an impact on the effectiveness of the treatment, but it also broadly impacts the patient’s quality of life. Another important unmet need in the management of hypertension in India is a dearth of data concerning the awareness, treatment patterns, control of hypertension, and the impact of treatment on the quality of life of patients.  

 

Therefore, the current real-world registry study aims to evaluate a larger hypertensive population treated in both private- and public-sector healthcare settings in India, to

• Understand current trends in hypertension in India, including clinical perspectives, disease management approaches, and hypertension-control strategies applied 

• Understand the course of patients with primary hypertension, including those with underlying risk factors or comorbid conditions, and to determine prognostic outcomes based on various lines of anti hypertensive drug 

• Evaluate and identify the criteria for hospitalization or up titration of anti hypertensive therapy to a higher dose or for the addition of a new drug from a different class 

• Obtain deeper knowledge of adherence to anti hypertensive drug treatment and to evaluate the quality of life in patients with essential hypertension in India 

• Identify factors affecting adherence to antihypertensive treatment Compare levels of adherence to different drug regimens 

• Understand treatment differences between public and private healthcare settings in India